Showing results (151-160 of 921) with videos related to

Sort By:
Pageof 93
Breast Cancer Research and Treatment|January 18, 2017
Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancerDing Ma, Yi-Zhou Jiang, Xi-Yu Liu, et al.
Oncology Reports|July 26, 2006
Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expressionHongyu Li, Shixuan Wang, Tao Zhu, et al.
Cancer Communications (London, England)|August 20, 2025
Lactylation in cancer biology: Unlocking new avenues for research and therapyXiaoyu Hou, Zhenya Hong, Huimin Zen, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|February 26, 2013
Analysis of birth defects among children 3 years after conception through assisted reproductive technology in ChinaLi Yin, Fu Hang, Long-jie Gu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|September 2, 2003
[PTEN coding product: a marker for tumorigenesis and progression of endometrial carcinoma]Qing-Lei Gao, Fei Ye, Jing Li, et al.
International Immunopharmacology|March 13, 2019
NLRX1 alleviates lipopolysaccharide-induced apoptosis and inflammation in chondrocytes by suppressing the activation of NF-κB signalingDing Ma, Yangxue Zhao, Jiang She, et al.
Surgical Oncology|August 26, 2019
Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institutionTing Hu, Yong Fang, Qian Sun, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|May 29, 2004
Dysregulation of the TGF-beta postreceptor signaling pathway in cell lines derived from primary or metastatic ovarian cancerLing Xi, Wei Hu, Li Meng, et al.
Oncology Reports|November 26, 2014
Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin AXiaoli Ma, Hua Duan, Jia Liu, et al.
Oncotarget|February 1, 2018
SF3B1 mutation is a poor prognostic indicator in luminal B and progesterone receptor-negative breast cancer patientsXing Fu, Ming Tian, Jia Gu, et al.
Pageof 93